Health
Sinovac – Phase I/II trial findings support use of CoronaVac vaccine in older individuals – Fintech Zoom
Sinovac – Phase I/II trial findings support use of CoronaVac vaccine in older individuals –
Sinovac – Phase I/II trial findings support use of CoronaVac vaccine in older individualsResearchers in China have reported phase I/II clinical trial findings showing that the vaccine candidate CoronaVac is well tolerated among older individuals and effectively generates antibody responses against severe acute respiratory syndrome coronavirus 2 (SARs-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
CoronaVac is an inactivated SARS-CoV-2 vaccine developed by Chinese pharmaceutical…
-
General16 hours agoCoroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner
-
General19 hours agoAlbanese beats drum on economy as trade clouds gather
-
Noosa News18 hours agoSurgeon partner of former premier to testify over his patient’s death
-
Business16 hours agoWhy Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher